← 返回前沿论文

微环境碱化促进 MSLN-CAR-T 细胞的治疗效果

英文原题:Microenvironmental alkalization promotes the therapeutic effects of MSLN-CAR-T cells.

PubMed 2024/10/21(内容时间) J Immunother Cancer Q1 · IF 11.7(JCR 2025)

研究概要

三阴性乳腺癌(TNBC)具有高侵袭性、易转移、频繁复发和预后差的特点。

中文摘要

三阴性乳腺癌(TNBC)具有高侵袭性、易转移、频繁复发和预后差的特点。遗憾的是,目前包括手术、放疗、化疗和免疫治疗在内的临床治疗手段对TNBC患者的疗效仍然有限。在本研究中,我们发现,由肿瘤微环境酸化引起的间皮素(MSLN)在蛋白水平和亚细胞定位上的异质性表达,可能是影响TNBC中CAR-T(CAR-T)细胞治疗疗效的主要障碍。碱化培养或给予碳酸氢钠显著促进了MSLN的膜表达,并在体外和体内均增强了MSLN-CAR-T细胞的杀伤效率,在胰腺癌和卵巢癌等其他高表达MSLN的癌症中也获得了相同的结果。此外,机制探索揭示,微环境碱化导致的自噬-溶酶体功能减弱抑制了MSLN的降解。因此,微环境碱化改善了靶抗原MSLN表达的一致性和高表达,构成了一种通过MSLN-CAR-T细胞治疗多种实体癌的常规方法。

展开英文摘要原文

Triple-negative breast cancer (TNBC) is characterized by high invasion, prone metastasis, frequent recurrence and poor prognosis. Unfortunately, the curative effects of current clinical therapies, including surgery, radiotherapy, chemotherapy and immunotherapy, are still limited in patients with TNBC. In this study, we showed that the heterogeneous expression at the protein level and subcellular location of mesothelin (MSLN), a potential target for chimeric antigen receptor-T (CAR-T) cell therapy in TNBC, which is caused by acidification of the tumor microenvironment, may be the main obstacle to therapeutic efficacy. Alkalization culture or sodium bicarbonate administration significantly promoted the membrane expression of MSLN and enhanced the killing efficiency of MSLN-CAR-T cells both in vitro and in vivo , and the same results were also obtained in other cancers with high MSLN expression, such as pancreatic and ovarian cancers. Moreover, mechanistic exploration revealed that the attenuation of autophagy-lysosome function caused by microenvironmental alkalization inhibited the degradation of MSLN. Hence, alkalization of the microenvironment improves the consistency and high expression of the target antigen MSLN and constitutes a routine method for treating diverse solid cancers via MSLN-CAR-T cells.

论文信息

作者
Wu M、Mao L、Zhai X、Liu J、Wang J、Li L、Duan J、Wang J
第一作者单位
Department of Stem Cell and Regenerative Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, Chongqing, China.China
通讯作者单位
Department of Stem Cell and Regenerative Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, Chongqing, China yushicang@163.com jianjunli@tmmu.edu.cn.China
期刊
Journal for immunotherapy of cancer2024 Oct 21
原文标识
PubMed 39433427 · DOI 10.1136/jitc-2024-009510